SENSEX NIFTY

Pharma

Dec 19, 2014 at 18:47 | Source: CNBC-TV18
A sell off by FIIs was somewhat offset by domestic buying amid reversal of trend as US Fed said it would be patient with interest rate hike
Dec 19, 2014 at 15:58 | Source: PTI
The collaboration has been established for an oral controlled release product utilising Panacea's platform of oral drug delivery technology, Panacea Biotec Ltd said in a statement.
Dec 19, 2014 at 13:00 | Source: Moneycontrol.com
Coal India, Reliance and Sesa Sterlite are up 3 percent. Wipro and ICICI Bank are top gainers in the Sensex. Among the losers are Bhati Airtel, HUL, ITC, Cipla and Sun Pharma.
Dec 18, 2014 at 12:34 | Source: CNBC-TV18
Nirmal Jain, Chairman at IIFL is of the view that one may prefer banking, IT and pharma stocks.
Dec 18, 2014 at 10:58 | Source: CNBC-TV18
Ambareesh Baliga, Independent Market Expert is of the view that one may buy Infosys, HCL Technologies and Sun Pharmaceutical Industries.
Dec 18, 2014 at 10:51 | Source: CNBC-TV18
In an interview to CNBC-TV18, Nirmal Jain, Chairman, IIFL, said the correction is over for the time being but it will depend on the movement in global markets.
Dec 18, 2014 at 10:07 | Source: Moneycontrol.com
Equity Mutual Funds ended in red as the equity benchmarks closed the session lower for the fifth consecutive session, after a massive intraday volatility on Wednesday.
Dec 17, 2014 at 17:29 | Source: Moneycontrol.com
Brokerage house Firstcall Research is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target price of Rs 913 in its research report dated December 04, 2014.
Dec 17, 2014 at 14:00 | Source: Moneycontrol.com
Hero Moto, ITC, Cipla, Bharti Airtel and Sun Pharma were major losers in the Sensex. Among the gainers were Sesa Sterlite, SBI, ONGC, Hindalco and Tata Steel.
Dec 17, 2014 at 13:00 | Source: Moneycontrol.com
Metal index is up over 1 percent led by Sesa Sterlite, Tata Steel and Hindalco. SBI and ONGC are up 2-3 percent each. ITC is still down 3 percent while Tata Power, Cipla, Hero Moto and Sun Pharma are still dragging 2 percent each.
Messages on Pharma »

subs74

Silver Member

3 Followers

Biocon  

Namo baba, at the end of the day its about fundamentals as also whether stock is in strong hands. pls look at other midcap pharma stocks like cadila, zydus,ipca. They have all gone up even on such a day despite having run up already which means they are in strong hands who dont allow the stocks

4.54 PM Jul 8th

abhishek_co
ssipore

New Member

1 Followers

Dishman Pharma  

Hold Dishman Pharma Targe Price 205

4.48 PM Jul 8th

subs74

Silver Member

3 Followers

Biocon  

I can understand a minor correction due to market sentiment but a 7% fall in a pharma stock like Biocon on the day of railway budget with which it has no correlation is strange. Either the correction is silly or the upmove itself in Biocon was not based on any fundamentals.

4.33 PM Jul 8th

Ajanta Pharma  

After AGM the share price will shoot up towards benefits to all investers - My target for Ajanta Pharma is Rs 2500 for the long term with a stoploss of Rs 1499

4.30 PM Jul 8th

Ravi_jangra

New Member

0 Follower

Alembic Pharma  

Salute to alembic pharma....All stocks down but alembic not....Guys today see alembic strong unbreakable resistance on 300/-.This is righttime to entre now or never...Save me today from huge lose

4.19 PM Jul 8th

jagoinvesto
r

Platinum Member

113 Followers

Morepen Lab  

morepen to buy sun pharma

4.15 PM Jul 8th

JPInvestor

New Member

0 Follower

SMS Pharma  

my view is that the equity base of SMS Pharma is very small and already having good profit. hence it can easily cross the above figures.

3.55 PM Jul 8th

subs74

Silver Member

3 Followers

Biocon  

How does budget affect pharma stocks like biocon?

3.47 PM Jul 8th

shmarketgen
ius

Platinum Member

610 Followers

Tech Mahindra  

suggest,that you try & find a small/mid- cap Pharma/IT/Auto Ancillary company or a consumer play.These stories are huuuge in size & will pay rich dividends.

3.47 PM Jul 8th

countryman

Platinum Member

643 Followers

Granules India  

For solving the problem of CAD, Re cannot go down so much to probably 53 levels which will hurt the exporters. I understand that RBI will control Re between 58 to 61 level so that exporters will get benefitted. Company has expanded their facilities, bought Auctus Pharma and this year Auctus

3.36 PM Jul 8th

News across the web »
Dec 17, 2014 at 13:37 | Source: Calcutta Telegraph News